http://web.archive.org/web/20131010004043id_/http://www.cnn.com/2012/11/30/health/fda-generic-lipitor

-- the @entity1 advised patients friday to keep taking a popular cholesterol drug even though it might contain specks of glass , reversing advice it gave just a day ago			1
millions of people take @entity9 's generic @entity8 , or atorvastatin , and many have been calling pharmacies confused about whether to take the drugs they have in their medicine cabinets			1
@entity9 initiated a recall november 9 and told pharmacies to stop dispensing the drug , but gave no advice to consumers about what to do with what was in their medicine cabinets			1
dr. @entity21 , director of the @entity1 's @entity22 , said the agency would review how it handles communication to the public during recalls			0
" it took us some time to figure out what was going on , " she said			0
" we need to fix our process a little bit			2
" @entity1 : stop taking recalled cholesterol drug between 3 million and 4 million people take @entity9 's atorvastatin , according to @entity35 , senior managing director at @entity36			1
the company has more than a 40 % share of the generic @entity8 market			1
the @entity1 made no public statements on the recall until thursday , when the agency said concerned patients should stop taking their medicine if their pharmacist confirmed it was from a recalled lot			2
after a conference call friday afternoon with pharmacies and other groups , the agency decided to change their guidance			1
" yesterday 's statement was poorly phrased , " @entity21 said friday			0
" it made people think they should stop taking their medicine			0
" the glass particles are " the size of a grain of sand , " she added			0
the pills " are n't of the quality we would expect of a drug , but they are n't risky , either , " @entity21 said			0
@entity9 has stopped making atorvastatin while they investigate how the glass got into the drug , according to the @entity1			2
recall leaves glass - specked drug in hands of patients			0

atorvastatin , or generic @entity8 , was recalled november 9
the @entity1 changed its guidance after a conference call with pharmacies and other groups
" we need to fix our process a little bit , " says @entity1 *official*

@entity22:Center for Drug Evaluation and Research
@entity1:FDA
@entity0:CNN
@entity35:Ross Muken
@entity36:ISI Group
@entity9:Ranbaxy
@entity8:Lipitor
@entity21:Woodcock